Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Dextrum Laboratories Inc.
FDA Inspection
•Dextrum Laboratories Inc.•July 18, 2023

Dextrum Laboratories Inc. – FDA Inspection, Jul 18, 2023

Record Details

This FDA Inspection record concerns Dextrum Laboratories Inc., with an inspection on July 18, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Dextrum Laboratories Inc.
Inspection Date
July 18, 2023
Product Type
Drugs
Office
Center for Drug Evaluation and Research
People
  • J'Maica J. Hunter (Investigator)
  • Joanne E. King (FDA Associated Person)
  • Samantha E. Cleek (Investigator)
View Company Profile

ID · 2f25f9cf-d18a-4e7e-a3bb-e453c55a547b

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1210295
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued
Enforcement
Warning Letter

FDA Citations

10
  1. 21 CFR 211.46(c)Exhaust systems inadequate to control air contamination
  2. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  3. 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
  4. 21 CFR 211.84(d)(2)Reports of Analysis (Components)
  5. 21 CFR 211.180(e)(1)Representative Number of Batches for Annual Review
  6. 21 CFR 211.110(a)Control procedures to monitor and validate performance
  7. 21 CFR 211.180(e)(1)Representative Number of Batches for Annual Review
  8. 21 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.
  9. 21 CFR 211.46(c)Exhaust systems inadequate to control air contamination
  10. 21 CFR 211.84(d)(2)Reports of Analysis (Components)

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Dextrum Laboratories Inc.

5
DateClassificationOfficeProject area
August 29, 2024OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 16, 2022VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 17, 2017VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 12, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
July 10, 2012VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Dextrum Laboratories Inc.
  • FDA Inspection 1249319 - 2024-08-29
  • FDA Inspection 1192929 - 2022-12-16
  • FDA Inspection 1031539 - 2017-11-17
  • FDA Inspection 965268 - 2016-02-12
  • FDA Inspection 790155 - 2012-07-10

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dextrum Laboratories Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.